Minimal Residual Disease (MRD) Testing Market by Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and Others), Application (Hematological Malignancy, Solid Tumors), End User (Hospitals and Speciality Clinics, Diagnostic Laboratories, Academic and Research Institutes, and Others), and Region 2025-2033

Minimal Residual Disease (MRD) Testing Market by Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and Others), Application (Hematological Malignancy, Solid Tumors), End User (Hospitals and Speciality Clinics, Diagnostic Laboratories, Academic and Research Institutes, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A7248

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Minimal Residual Disease (MRD) Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Technology
    6.1    Flow Cytometry
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Polymerase Chain Reaction (PCR)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Next Generation Sequencing (NGS)
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Application
    7.1    Hematological Malignancy
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 Leukemia
           7.1.2.2 Lymphoma
        7.1.3 Market Forecast
    7.2    Solid Tumors
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by End User
    8.1    Hospitals and Speciality Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Diagnostic Laboratories
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Academic and Research Institutes
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  Drivers, Restraints, and Opportunities
    10.1    Overview
    10.2    Drivers
    10.3    Restraints
    10.4    Opportunities
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Adaptive Biotechnologies Corporation
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
        14.3.2    Arup Laboratories Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 SWOT Analysis
        14.3.3    Bio-Rad Laboratories Inc. 
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Guardant Health
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    Invivoscribe Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Natera Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
        14.3.7    NeoGenomics Laboratories Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
        14.3.8    Sysmex Corporation 
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

Figure 1: Global: Minimal Residual Disease Testing Market: Major Drivers and Challenges
Figure 2: Global: Minimal Residual Disease Testing Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Minimal Residual Disease Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Minimal Residual Disease Testing Market: Breakup by Technology (in %), 2024
Figure 5: Global: Minimal Residual Disease Testing Market: Breakup by Application (in %), 2024
Figure 6: Global: Minimal Residual Disease Testing Market: Breakup by End User (in %), 2024
Figure 7: Global: Minimal Residual Disease Testing Market: Breakup by Region (in %), 2024
Figure 8: Global: Minimal Residual Disease Testing (Flow Cytometry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Minimal Residual Disease Testing (Flow Cytometry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Minimal Residual Disease Testing (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Minimal Residual Disease Testing (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Minimal Residual Disease Testing (Next Generation Sequencing (NGS)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Minimal Residual Disease Testing (Next Generation Sequencing (NGS)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Minimal Residual Disease Testing (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Minimal Residual Disease Testing (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Minimal Residual Disease Testing (Hematological Malignancy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Minimal Residual Disease Testing (Hematological Malignancy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Minimal Residual Disease Testing (Solid Tumors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Minimal Residual Disease Testing (Solid Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Minimal Residual Disease Testing (Hospitals and Speciality Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Minimal Residual Disease Testing (Hospitals and Speciality Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Minimal Residual Disease Testing (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Minimal Residual Disease Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Minimal Residual Disease Testing (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Minimal Residual Disease Testing (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Minimal Residual Disease Testing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Minimal Residual Disease Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: North America: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: North America: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: United States: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: United States: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Canada: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Canada: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Asia-Pacific: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Asia-Pacific: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: China: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: China: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Japan: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Japan: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: India: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: India: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: South Korea: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: South Korea: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Australia: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Australia: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Indonesia: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Indonesia: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Others: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Others: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Europe: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Europe: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Germany: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Germany: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: France: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: France: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: United Kingdom: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: United Kingdom: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Italy: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Italy: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Spain: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Spain: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Russia: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Russia: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Others: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Others: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Latin America: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Latin America: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Brazil: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Brazil: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Mexico: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Mexico: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Others: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Others: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Middle East and Africa: Minimal Residual Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Middle East and Africa: Minimal Residual Disease Testing Market: Breakup by Country (in %), 2024
Figure 76: Middle East and Africa: Minimal Residual Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Global: Minimal Residual Disease Testing Industry: Drivers, Restraints, and Opportunities
Figure 78: Global: Minimal Residual Disease Testing Industry: Value Chain Analysis
Figure 79: Global: Minimal Residual Disease Testing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Minimal Residual Disease Testing Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Minimal Residual Disease Testing Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 3: Global: Minimal Residual Disease Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Minimal Residual Disease Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Minimal Residual Disease Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Minimal Residual Disease Testing Market: Competitive Structure
Table 7: Global: Minimal Residual Disease Testing Market: Key Players

Minimal Residual Disease (MRD) Testing Market by Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and Others), Application (Hematological Malignancy, Solid Tumors), End User (Hospitals and Speciality Clinics, Diagnostic Laboratories, Academic and Research Institutes, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials